Endurance training-induced changes in the GH-IGF-I axis influence maximal muscle strength in previously untrained men

Objective: In this study we have determined the effects of 20 weeks of endurance running training on the GH-IGFI axis changes in the context of the skeletal muscle performance and physical capacity level. Design: Before and after the endurance training program a maximal incremental exercise tests, a 1500 m race and a muscle strength measurements were performed and the blood samples were taken to determine both resting as well as end-exercise serum growth hormone (GH), insulin-like growth hormone-I (IGF-I), insulin-like growth hormone binding protein-3 (IGFBP-3) and plasma interleukin-6 (IL-6) concentrations. Results: 20 weeks of endurance running training improved power output generated at the end of the maximal incremental test by 24% (P < 0.012),1500 m running time by 13% (P < 0.012) and maximal muscle strength by 9% (P < 0.02). End-exercise IGF-I/IGFBP-3 ratio was decreased by 22% after the training (P < 0.04) and the magnitude of IGF-I/IGFBP-3 ratio decrease (Delta IGF-I/IGFBP-3(ex)) was 23 times higher after the training (P < 0.04). The magnitude of the exercise-induced changes in IGFBP-3 concentration was also significantly higher (P < 0.04) and there was a trend toward lower end-exercise IGF-I concentration (P = 0.08) after the training. These changes were accompanied by a significantly higher (30%) end-exercise IL-6 concentration (P < 0.01) as well as by a 3.4 times higher magnitude of IL-6 increase (P < 0.02) after the training. Moreover, there were strong positive correlations between changes in resting serum IGF-I concentration (Delta IGF-I,) and IGF-I/IGFBP-3 ratio (Delta IGF-I/ IGFBP-3(res)) and changes in muscle strength (Delta MVC) (r = 0.95, P = 0.0003 and r = 0.90, P = 0.002, respectively). Conclusions: The training-induced changes in the components of the GH-IGF-I axis may have additive effects on skeletal muscle performance and physical capacity improvement. (C) 2016 Elsevier Ltd. All rights reserved.